Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Hitoshi Arioka"'
Autor:
Takuhiro Yamaguchi, Tempei Miyaji, Hirotoshi Iihara, Yasushi Ohno, Takako Eguchi Nakajima, Chikatoshi Katada, Takashi Kawaguchi, Hiroko Minatogawa, Naoki Izawa, Kazuhiro Shimomura, Honda Kazunori, Yusuke Inada, Hitoshi Arioka, Hajime Morita, Naoya Hida, Mitsuhiro Sugawara, Shuichi Nawata, Hiroo Ishida, Takashi Tsuda
Publikováno v:
BMJ Open, Vol 10, Iss 12 (2020)
Introduction Dexamethasone (DEX) is administered for multiple days to prevent chemotherapy-induced nausea and vomiting for patients receiving highly emetogenic chemotherapy (HEC); however, its notorious side effects have been widely reported. Althoug
Externí odkaz:
https://doaj.org/article/b035f200f8874e499b4b1025fbd8bd51
Autor:
Hiroji Iwata, Nami Yamashita, Fimikata Hara, Tatsuya Toyama, Rikiya Nakamura, Junji Tsurutani, Yasuaki Sagara, Toshiro Mizuno, Masaya Hattori, Shigenori Nagai, Yoichi Naito, Naoto Kondo, Hitoshi Arioka, Naoki Hayashi, Yuichiro Kikawa, Minoru Miyashita, Tatsunori Shimoi, Mikiya Ishihara, Toshimi Takano, Kei Koizumi, Masato Takahashi, Masahiro Takada, Tetsuhiro Yoshinami, Shigehira Saji, Takashi Yamanaka
Publikováno v:
Breast Cancer (Tokyo, Japan)
Purpose We present the English version of The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition. Methods The JBCS formed a task force to update the JBCS Clinical Practice Guidelin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe5090068e68f1c097855c25df4d9335
http://europepmc.org/articles/PMC8062371
http://europepmc.org/articles/PMC8062371
Autor:
Jun Saitou, Tomoko Takiguchi, Haremaru Kubo, Rei Hirose, Sho Katsuragawa, Hiroko Yukawa, Naoko Yamamoto, Hitoshi Arioka, Tetsuo Nishikawa, Yoshitomo Hoshino, Takashi Sunouchi, Yuya Tsurutani, Masahiro Ichikawa
Publikováno v:
Internal Medicine
A 77-year-old-man with renal cell carcinoma who was undergoing nivolumab treatment visited our department due to hyperglycemia; his plasma glucose level was 379 mg/dL. Although his serum C-peptide immunoreactivity (CPR) level was preserved (5.92 ng/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55512fe5f2e902124d361f73ffb165f3
http://europepmc.org/articles/PMC6815891
http://europepmc.org/articles/PMC6815891
Autor:
Kazuya Abe, Yuichi Ishikawa, Michio Fujiwara, Hiroko Yukawa, Takeshi Yanagihara, Saori Takei, Hitoshi Arioka, Yasuhiko Kita
Publikováno v:
Medicine
Rationale: Immune checkpoint inhibitors (ICIs) have shown efficacy for the treatment of various kinds of malignant tumors. However, ICIs can cause immune-related adverse events, such as arthritis. Nevertheless, the treatment of ICI-induced arthritis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::617fb3f79ac035211a3433bbdf9ab600
https://doi.org/10.1097/md.0000000000028428
https://doi.org/10.1097/md.0000000000028428
Autor:
Tatsuji Yogi, Masayuki Imamura, Gou Murohisa, Susumu Hijioka, Kazuo Hara, Shigeru Horiguchi, Mitsuhiro Furuta, Izumi Komoto, Hitoshi Shibuya, Hitoshi Arioka, Takuji Okusaka, Masafumi Ikeda, Atsushi Kudo, Sho Kiritani, Hiroshi Imaoka, Yoshikuni Nagashio, Fumito Imamura, Yasunari Sakamoto, Michio Senju, Masayo Motoya, Hiroaki Yasuda, Makoto Ueno, Hayato Miyake, Keijiro Ueda, Shigemi Matsumoto, Tetsuro Kawagoe, Tetsuhide Ito, S. Kobayashi, Noritoshi Kobayashi, Taku Aoki, Youichi Miyaoka, Nobuaki Azemoto, Jun Itakura, Junichi Arita
Publikováno v:
Cancer Chemotherapy and Pharmacology. 82:661-668
Streptozocin (STZ) is a key agent for treating advanced pancreatic neuroendocrine tumors (pNET). Most STZ regimens for pNET are daily and also include 5-fluorouracil (5FU), whereas STZ monotherapy and weekly regimens have also been applied in daily p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f62392df0446c32c9cd96163fbfd2b11
https://doi.org/10.1007/s00280-018-3656-y
https://doi.org/10.1007/s00280-018-3656-y
Autor:
Yuka Ito, Satoshi Morita, Mamoru Fukuda, Takako Eguchi Nakajima, Yasuyuki Kojima, Yutaka Tokuda, Narikazu Boku, Ichiro Ohta, Takashi Tsuda, Takeharu Yamanaka, Koichiro Tsugawa, Ayako Tsuboya, Kazutaka Narui, Kentaro Sakamaki, Masahiko Ando, Takashi Suda, Sadatoshi Sugae, Hitoshi Arioka, Naoki Furuya, Kunihiro Matsuzaki, Hiroko Minatogawa, Sayaka Kano
Publikováno v:
Journal of Clinical Oncology. 36:1000-1006
Purpose We evaluated the noninferiority of dexamethasone (DEX) on day 1, with sparing on days 2 and 3, combined with neurokinin-1 receptor antagonist (NK1-RA) and palonosetron (Palo) compared with the 3-day use of DEX in highly-emetogenic chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00c47a4424c08755715263a06f1eb13c
https://doi.org/10.1200/jco.2017.74.4375
https://doi.org/10.1200/jco.2017.74.4375
Publikováno v:
Annals of Oncology. 32:S358
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07ac803974e77fe19db0b17fadddaa46
https://doi.org/10.1016/j.annonc.2021.05.781
https://doi.org/10.1016/j.annonc.2021.05.781
Autor:
Shintaro Takao, Kenjiro Aogi, Naohito Yamamoto, Masahiro Kashiwaba, Junichiro Watanabe, Hitoshi Arioka, Hideko Yamauchi, Takanori Ishida, Kimito Yamada, Takahiro Nakayama, Mitsue Saito, Hiroji Iwata, Yasuhiro Fujiwara, Kenji Tamura, Toshiaki Saeki, Yutaka Tokuda, Shinji Ohno, Hiroshi Ishiguro, Nobuaki Sato, Kenichi Inoue, Tatsuya Toyama, Norikazu Masuda
Publikováno v:
Cancer Science
Weekly administration of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) has been shown to be a safe and effective treatment for metastatic breast cancer (MBC) in clinical studies. We conducted a multicenter, randomized, open-label phase II st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21b252cb2652bc32df6066d9d73f1dea
http://europepmc.org/articles/PMC5448660
http://europepmc.org/articles/PMC5448660
Autor:
Takashi Chishima, Kazutaka Narui, Yuki Saito, Norihiko Sengoku, Takeshi Sasaki, T Doi, Hitoshi Arioka, Masaru Kuranami, T Ota, Daisuke Shimizu, S Nawata, Koichiro Tsugawa, Yutaka Tokuda, Oba, Takeshi Ishikawa, Yoshimasa Kosaka, M Mogaki, H Ogata, Itaru Endo, Kumiko Kida, Mikiko Tanabe, Yasuhiro Suzuki, A Suto, Yasushi Ichikawa, Satoshi Morita
Publikováno v:
Cancer Research. 77:P5-16
Purpose: This study aimed to evaluate response to neoadjuvant chemotherapy (NAC) for patients with hormone receptor-negative (HR-negative) breast cancer (BC) to identify subtypes that require anthracycline treatment. Methods: In total, 103 patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27f67a6fa0ca765bf3a040eeba6527c0
https://doi.org/10.1158/1538-7445.sabcs16-p5-16-04
https://doi.org/10.1158/1538-7445.sabcs16-p5-16-04
Autor:
Hisashi Hidaka, Susumu Kanazawa, Namiki Izumi, Junji Furuse, Kazuho Imanaka, Masafumi Ikeda, Masatoshi Kudo, Shuichi Kaneko, Tatsuya Yamashita, Satoshi Morita, Hiroya Saito, Takeshi Aramaki, Hitoshi Arioka, Takuji Okusaka, Yoshitaka Inaba, Shinichi Kora, Osamu Yokosuka, Yasuaki Arai, Osamu Matsui
Publikováno v:
Medical oncology (Northwood, London, England). 36(6)
A randomized, phase III trial of orantinib in combination with transcatheter arterial chemoembolization (TACE) did not prolong overall survival (OS) over placebo (ORIENTAL study). A subgroup analysis was conducted to evaluate the efficacy and safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4df1173a39af0771d65c2f49e2f7e484
https://pubmed.ncbi.nlm.nih.gov/31053989
https://pubmed.ncbi.nlm.nih.gov/31053989